The Epigenetic Clock Development Foundation (EIN: 85-1457272) is a nonprofit organization dedicated to advancing rigorous medical research on aging and longevity through the development of epigenetic clocks as biomarkers. With an operating budget of $1.8 million and total revenue of $2.1 million for the 2024 filing year, the foundation seeks to test the effectiveness of longevity treatments in preclinical and clinical studies. The organization does not rely on a single funder for 50% or more of its revenue and can be found online at www.clockfoundation.org.